This is an old revision of this page, as edited by Arcadian (talk | contribs) at 13:37, 23 November 2005 (Reverted edits by 202.67.103.253 to last version by Arcadian). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 13:37, 23 November 2005 by Arcadian (talk | contribs) (Reverted edits by 202.67.103.253 to last version by Arcadian)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
A tetracyclic antidepressant is an antidepressant drug from the tetracyclic drug group.
The name tetracyclic is derived from the drug's molecular structure which consists of four ring like structures (compare tricyclic antidepressant).
Maprotiline, trade named Ludiomil®, and Mirtazapine, trade named Remeron® in the USA and Zispin® in Europe, are the only two drugs from this group widely used for the treatment of clinical depression. The tetracyclic antidepressant Mianserin was previously available internationally, however in most markets it has been phased out in favor of Mirtazepine.
Research on other tetracyclic antidepressant compounds (for example setiptiline) have been reported in the scientific literature. These other tetracyclic antidepressants are not publicly available.
There are also several chemically unrelated tetracyclic antibiotics based on Tetracycline.
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |